Fortis HealthcareNSE:FORTIS -2.11%84 EBITDA Margin % is 22.43% as of Mar. 2026, which is 15% above its 10-year median of 19.53. GuruFocus rates NSE:FORTIS with a GF Score™ of 84/100 and a GF Value™ of ₹807.01 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Fortis Healthcare ranks better than 81.59% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Fortis Healthcare's EBITDA for the
three
months ended in Mar. 2026 was ₹5,305 Mil. Fortis Healthcare's Revenue for the
three
months ended in Mar. 2026 was ₹23,647 Mil. Therefore, Fortis Healthcare's EBITDA margin for the quarter that ended in Mar. 2026 was 22.43%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Fortis Healthcare EBITDA Margin % Related Terms
Fortis Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Fortis Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:FORTIS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Fortis Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Fortis Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortis Healthcare (NSE:FORTIS) has a EBITDA Margin % of 22.43% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fortis Healthcare and its competitors. This is 15% above median its historical median of 19.53. According to the industry distribution chart, Fortis Healthcare ranks #123 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 18.4%.
Is Fortis Healthcare's EBITDA Margin % too high?
Fortis Healthcare's current EBITDA Margin % of 22.43% is 15% above median its 10-year median of 19.53. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Fortis Healthcare's value of 22.43% is 119.7% above this industry median. Based on the distribution chart, Fortis Healthcare ranks #123 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fortis Healthcare has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortis Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Healthcare ranks #123 out of 668 companies for EBITDA Margin %. This places Fortis Healthcare in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Fortis Healthcare's value of 22.43% is 119.7% above this benchmark. While the company's 10-year median is 19.53 vs. the industry median of 10.21, Fortis Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fortis Healthcare's current EBITDA Margin % of 22.43% is 119.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fortis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Healthcare's current EBITDA Margin % is 22.43%, which is 15% above median its own 10-year median of 19.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fortis Healthcare (NSE:FORTIS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹807.01, compared to a current price of ₹954.80 — trading 18.3% above its estimated fair value. The current EBITDA Margin % is 22.43%, which is 15% above median its 10-year median of 19.53 and 119.7% above the Healthcare Providers & Services industry median of 10.21. Fortis Healthcare's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Fortis Healthcare (NSE:FORTIS), the current EBITDA Margin % is 22.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortis Healthcare (NSE:FORTIS) Overvalued in 2026?
Based on GuruFocus' analysis, Fortis Healthcare stock appears to be overvalued.
The current stock price of ₹954.80 is trading 18.3% above its estimated GF Value™ of ₹807.01.
GuruFocus considers Fortis Healthcare to be Modestly Overvalued.
Key valuation signals for NSE:FORTIS:
EBITDA Margin %: 22.43% (15% above median its 10-year median of 19.53)
GF Value™: ₹807.01 vs. price of ₹954.80 (18.3% above fair value)
Industry Position: 119.7% above the Healthcare Providers & Services median (#123 of 668)
No single metric tells the full story. See the NSE:FORTIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortis Healthcare Ltd provides integrated healthcare delivery services in India. The company manages healthcare centers including hospitals, diagnostics, and day care specialty facilities. The company's key specialty in its hospital business is cardiac sciences. It is predominantly engaged in the business of healthcare services which is the only reportable segment. The company's key hospitals include Fortis Escorts Heart Institute in Dehli, Fortis Mulund in Mumbai, and Fortis Hospital in Bengaluru. The majority of the company's revenue is derived from India.
84GF Score
Get the complete analysis for NSE:FORTIS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FORTIS has been successfully added to your 
